Kinesiophobia and Functional Outcomes in Hand Injuries
The Effect of Kinesiophobia Level on Functional Outcomes in Surgically Performed Hand Injuries
Hand and forearm injuries are among the most common traumatic injuries and may result in substantial functional limitations, reduced work capacity, and decreased quality of life. Despite advances in surgical repair techniques, recovery outcomes vary considerably among individuals with similar injury characteristics. Psychological factors, particularly fear of movement or reinjury (kinesiophobia), may influence rehabilitation participation and functional recovery after injury.
The aim of this prospective observational study is to investigate the relationship between early kinesiophobia levels and functional outcomes in adults who undergo surgical treatment for traumatic hand or forearm lacerations. Kinesiophobia will be assessed during the acute post-injury period (within 1-5 days after injury) using the Tampa Scale of Kinesiophobia. Injury severity will be evaluated using the Modified Hand Injury Severity Classification (MHISC/MEYCS).
Participants will be followed for 12 weeks after injury. Functional recovery will be assessed at the 8th week using the Buck-Gramcko Score and the Sollerman Hand Function Test, and at the 12th week using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and hand grip strength measurements.
The study will examine whether higher levels of early kinesiophobia are associated with greater injury severity and poorer functional recovery. Findings from this study may help identify patients at risk for delayed recovery and support the development of early rehabilitation strategies targeting psychological as well as physical aspects of hand injury recovery.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Samir İlgaroğlu, Surgeon
- Telefonnummer: +905536166156
- E-Mail: doktorsamir.zeynal@gmail.com
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
Adults aged 18 years and older. Patients presenting to the emergency department with traumatic hand or forearm lacerations requiring surgical treatment.
Injury involving one or more anatomical structures of the hand or forearm (skin, tendon, nerve, vessel, or combined injuries).
Assessment within 1-5 days following injury. Ability to understand and complete study questionnaires and functional assessments.
Provision of written informed consent. Willingness to participate in follow-up assessments at 8 and 12 weeks after injury.
Exclusion Criteria:
Age younger than 18 years. Cognitive impairment, severe psychiatric disorder, or communication problems preventing completion of questionnaires.
Previous major injury, surgery, or permanent functional impairment of the affected upper extremity.
Polytrauma or additional injuries that may substantially affect upper extremity function or rehabilitation outcomes.
Neurological disorders affecting upper extremity function (e.g., stroke, peripheral neuropathy, spinal cord injury).
Severe musculoskeletal disorders of the upper extremity unrelated to the index injury.
Inability or unwillingness to attend follow-up evaluations. Refusal to provide informed consent
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Minor Injury Group
Participants with traumatic hand or forearm injuries classified as minor according to the Modified Hand Injury Severity Classification (MHISC/MEYCS) score (MEYCS <20).
Patients will undergo standard surgical treatment and routine postoperative care and will be followed for assessment of kinesiophobia and functional outcomes.
|
Participants with traumatic hand or forearm injuries will receive surgical treatment and postoperative management according to routine clinical practice and the treating surgeon's decision.
No experimental treatment, device, medication, or rehabilitation protocol will be administered as part of the study.
The study is observational in nature and aims to evaluate the relationship between early kinesiophobia levels, injury severity, and subsequent functional outcomes following standard surgical care.
Andere Namen:
|
|
Experimental: Moderate Injury Group
Participants with traumatic hand or forearm injuries classified as moderate according to the Modified Hand Injury Severity Classification (MHISC/MEYCS) score (MEYCS 21-50).
Patients will undergo standard surgical treatment and routine postoperative care and will be followed for assessment of kinesiophobia and functional outcomes.
|
Participants with traumatic hand or forearm injuries will receive surgical treatment and postoperative management according to routine clinical practice and the treating surgeon's decision.
No experimental treatment, device, medication, or rehabilitation protocol will be administered as part of the study.
The study is observational in nature and aims to evaluate the relationship between early kinesiophobia levels, injury severity, and subsequent functional outcomes following standard surgical care.
Andere Namen:
|
|
Experimental: Severe Injury Group
Participants with traumatic hand or forearm injuries classified as severe according to the Modified Hand Injury Severity Classification (MHISC/MEYCS) score (MEYCS 51-100).
Patients will undergo standard surgical treatment and routine postoperative care and will be followed for assessment of kinesiophobia and functional outcomes.
|
Participants with traumatic hand or forearm injuries will receive surgical treatment and postoperative management according to routine clinical practice and the treating surgeon's decision.
No experimental treatment, device, medication, or rehabilitation protocol will be administered as part of the study.
The study is observational in nature and aims to evaluate the relationship between early kinesiophobia levels, injury severity, and subsequent functional outcomes following standard surgical care.
Andere Namen:
|
|
Experimental: Major Injury Group
Participants with traumatic hand or forearm injuries classified as major according to the Modified Hand Injury Severity Classification (MHISC/MEYCS) score (MEYCS >101).
Patients will undergo standard surgical treatment and routine postoperative care and will be followed for assessment of kinesiophobia and functional outcomes.
|
Participants with traumatic hand or forearm injuries will receive surgical treatment and postoperative management according to routine clinical practice and the treating surgeon's decision.
No experimental treatment, device, medication, or rehabilitation protocol will be administered as part of the study.
The study is observational in nature and aims to evaluate the relationship between early kinesiophobia levels, injury severity, and subsequent functional outcomes following standard surgical care.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Disabilities of the Arm, Shoulder and Hand (DASH) Score
Zeitfenster: 12 weeks after injury
|
Functional disability and symptoms of the upper extremity assessed using the Turkish version of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.
The study will evaluate the association between early kinesiophobia levels measured within 1-5 days after injury and functional outcomes at 12 weeks following surgically treated hand and forearm injuries.
|
12 weeks after injury
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Hand Grip Strength
Zeitfenster: 12 weeks after injury
|
Grip strength of the injured hand measured using a standard hand dynamometer.
Three measurements will be obtained and the mean value will be recorded.
|
12 weeks after injury
|
|
Buck-Gramcko Functional Score
Zeitfenster: 8 weeks after injury
|
Hand function, pain, and range of motion assessed using the Buck-Gramcko scoring system to evaluate intermediate-term functional recovery.
|
8 weeks after injury
|
|
Sollerman Hand Function Test Score
Zeitfenster: 8 weeks after injury
|
Hand function during activities of daily living assessed using the Sollerman Hand Function Test.
|
8 weeks after injury
|
|
Tampa Scale of Kinesiophobia (TSK) Score
Zeitfenster: Within 1-5 days after injury
|
Fear of movement and reinjury assessed using the Turkish version of the Tampa Scale of Kinesiophobia during the acute post-injury period.
|
Within 1-5 days after injury
|
|
Modified Hand Injury Severity Classification (MHISC/MEYCS) Score
Zeitfenster: Within 1-5 days after injury
|
Injury severity assessed using the Modified Hand Injury Severity Classification (MEYCS) at the time of initial evaluation.
|
Within 1-5 days after injury
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- MarmaraUni-01
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .